Click here for more sample CPC practice exam questions with Full Rationale Answers

Practice Exam

Click here for more sample CPC practice exam questions and answers with full rationale

Practice Exam

CPC Practice Exam and Study Guide Package

Practice Exam

What makes a good CPC Practice Exam? Questions and Answers with Full Rationale

CPC Exam Review Video

Laureen shows you her proprietary “Bubbling and Highlighting Technique”

Download your Free copy of my "Medical Coding From Home Ebook" at the top right corner of this page

Practice Exam

2018 CPC Practice Exam Answer Key 150 Questions With Full Rationale (HCPCS, ICD-9-CM, ICD-10, CPT Codes) Click here for more sample CPC practice exam questions with Full Rationale Answers

Practice Exam

Click here for more sample CPC practice exam questions and answers with full rationale

FQHC Dual encounters, what constitutes “significant additional work”

When working pediatric notes, as an FQHC we are allowed to bill for a dual visit "whenever a problem or abnormality (i.e., exercise-induced asthma, migraine headaches, otitis media, prescription management) is addressed and requires significant additional work to perform the required key components and is medically necessary". We have a note that is documented as "stable on medication, but on drug holiday for the summer. Gave mom instructions on how to restart medications". Can I get your thoughts on if this would fall under prescription drug management?
:confused:
What is a general length of time to which "restarting medication" is considered significant? Your input is greatly appreciated.

Medical Billing and Coding Forum

Definition of “significant” for modifier 25

What makes an E/M "significant" enough to warrants a claim with modifier 25 the same day as a minor procedure?

Humana has informed us that they will only pay an E/M with modifier 25 if the problem was significant enough to require a prescription, lab order, surgery recommendation, or something like that. If it only requires counseling or OTC medication, it is not "significant" enough to bill a separate E/M.

Example: Pt came in for evaluation of a rash, and the provider examined the area and recommended an OTC cream. The provider happened to notice an unrelated suspicious lesion and performed a biopsy. So we billed 11100 for the lesion and 99212-25 for the rash. Humana denied the 99212-25 stating that the rash was not a "significant" enough problem to bill separately because the recommendation was only for OTC medication.

Is this appropriate?

Medical Billing and Coding Forum